Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2014, Vol. 34 Issue (5): 122-129    DOI: 10.13523/j.cb.20140517
    
The Birth and Development of Tissue Engineering
WANG Dian-liang
Tissue Engineering and Regenerative Medicine Laboratory, The Second Artillery General Hospital, Beijing 100088, China
Download: HTML   PDF(738KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

The traditional organ transplantation could not meet the need of the clinical treatment for the restrictions such as organ origin, ethic and body immunity. Tissue engineering therefore come to birth and proceed to grow by responding to successive challenges. At the beginning, the definition of tissue engineering was that a combined utilization of cells with scaffold materials and bioactive factors could be an efficient way to promote the research and application of tissue repair and regeneration. With the deep investigation in this field, the tissue engineering concept was also developed. Modern tissue engineering is an interdisciplinary branch of science that study and develop bioactive artificial substitution to maintain, restore or improve the function of the damaged human tissues by use of the principles of engineering science and life science. Since the birth of more than two decades, the development of tissue engineering has experienced about three stages. Regenerative medicine is an important branch science of modern clinical science, which is closely related with stem cell and tissue engineering. Tissue engineering is a perfect tissue organ regeneration, key research field of regenerative medicine, and main development direction of regenerative medicine. The principles and techniques of regenerative medicine promote the development of tissue engineering.



Key wordsOrgan transplantation      Regenerative Medicine      Tissue engineering     
Received: 03 April 2014      Published: 25 May 2014
ZTFLH:  Q954  
Cite this article:

WANG Dian-liang. The Birth and Development of Tissue Engineering. China Biotechnology, 2014, 34(5): 122-129.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20140517     OR     https://manu60.magtech.com.cn/biotech/Y2014/V34/I5/122


[1] Toso C, Cader S, Mentha-Dugerdil A, et al. Factors predicting survival after post-transplant hepatocellular carcinoma recurrence. J Hepatobiliary Pancreat Sci, 2013, 20(3): 342-347.

[2] Soto-Gutierrez A, Wertheim J A, Ott H C, et al. Perspectives on whole-organ assembly: moving toward transplantation on demand. J Clin Invest, 2012, 122(11): 3817-3823.

[3] Lee J H, Hong S Y, Oh C K, et al. Kidney Transplantation from a donor following cardiac death supported with extracorporeal membrane oxygenation. J Korean Med Sci, 2012, 27(2): 115-119.

[4] Hollister S J, Murphy W L. Scaffold translation: barriers between concept and clinic. Tissue Eng Part B Rev, 2011, 17(6): 459-474.

[5] Ikada Y. Challenges in tissue engineering. J R Soc Interface, 2006, 3(10): 589-601.

[6] Yannas IV, Burke J F, Gordon PL,et al. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res, 1980, 14(2):107-132.

[7] Wolter J R, Meyer R F. Sessile macrophages forming clear endothelium-like membrane on inside of successful keratoprosthesis. Trans Am Ophthalmol Soc, 1984, 82:187-202.

[8] Vacanti J P, Morse M A, Saltzman W M, et al. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg, 1988, 23:3-9.

[9] Langer R, Vacanti J P. Tissue engineering. Science, 1993, 260(5110):920-926.

[10] Machingal M A, Corona B T, Walters T J, et al. A Tissue-Engineered Muscle Repair Construct for Functional Restoration of an Irrecoverable Muscle Injury in a Murine Model. Tissue Eng Part A, 2011, 17(17-18): 2291-2303.

[11] Magarian E M, Vavken P, Connolly S A, et al.Safety of intra-articular use of atelocollagen for enhanced tissue repair. Open Ortho PJ 2012, 6: 231-238.

[12] Kretlow J D, Young S, Klouda L, et al. Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater, 2009, 21(32-33): 3368-3393.

[13] Shearn J T, Kinneberg K R C, Dyment N A, et al. Tendon tissue engineering: progress, challenges, and translation to the clinic.J Musculoskelet Neuronal Interact, 2011, 11(2): 163-173.

[14] Amini A R, Laurencin C T, Nukavarapu S P.Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng 2012,40(5): 363-408.

[15] Tabata Y. Biomaterial technology for tissue engineering applications. J R Soc Interface 2009, 6(Suppl 3): S311-S324.

[16] Cima L G, Vacanti J P, Vacanti C, et al. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng, 1991,113(2):143-151.

[17] Freed L E, Langer R, Martin I, et al. Tissue engineering of cartilage in space. Proc Natl Acad Sci USA, 1997,9;94(25):13885-13890.

[18] Haisch A.Ear Reconstruction through tissue engineering. Adv Otorhinolaryngol,2010, 68:108-119.

[19] Cao Y L, Vacanti J P, Paige K T, et al. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg, 1997, 100(2):297-302.

[20] Atala A, Bauer S B, Soker S, et al. Tissue-engineered autologous bladders for patients needing cystoplasty. The Lancet, 2006, 367(9518):1241~1246

[21] Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway. The Lancet, 2008,372(9655):2023-2030.

[22] Peck M, Gebhart D, Dusserre N, et al.The Evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs, 2011,195(1-2): 144-158.

[23] O'Keefe R J, Mao J M.Bone Tissue Engineering and regeneration: from discovery to the clinic—an overview.Tissue Eng Part B Rev, 2011,17(6): 389-392.

[24] Tang M, Chen W, Weir M D, et al.Human embryonic stem cell-encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering Acta Biomater,2013, 8(9): 3436-3445.

[25] Rytlewski J A, Geuss L R, Anyaeji C I, et al. Three-dimensional image quantification as a new morphometry method for tissue engineering. Tissue Eng Part C Methods, 2012, 18(7): 507-516.

[26] 陈伟,姜平. 活性真皮替代物的体内外实验. 中国组织工程研究, 2012,16(51):9607-9610. Chen W, Jiang P.In vivo and in vitro experiments of living derm substitute.Chinese Journal of Tissue Engineering Research,2012,16(51):9607-9610.

[27] 张利难,冯瑞铮,张宝林. 应用富含血小板血浆构建组织工程骨的研究. 中国当代医药, 2013, 20(23):20-23. Zhang L N,Feng R ZH,Zhang B L.The experiment of constructing tissue engineering bone with platelet-rich Plasma.China Modern Medicine.2013,20(23):20-23.

[28] 杜娟,王佃亮,张艳梅,孙晋伟. 组织工程面临的挑战与发展趋势.中国生物工程杂志, 2011,31(6):142-148. Du J,Wang D L,Zhang Y M,et al.Challenges and prospects of tissue engineering.China Biotechnology,2011,31(6):142-148.

[29] 张艳梅,王佃亮,孙晋伟.3D仿生组织工程支架及其在再生医学中的应用.解放军医学杂志, 2011,36(6):680-683.

[30] Orlando G, Wood K J, Coppi P D, et al. Regenerative medicine as applied to general surgery. Ann Surg, 2012, 255(5): 867-880.

[31] Pitt D, Aubin J M. Joseph Lister: father of modern surgery.Can J Surg, 2012, 55(5): E8-E9.

[32] Yildirim S, Fu S Y, Kim K, Zhou H, et al. Tooth regeneration: a revolution in stomatology and evolution in regenerative medicine. Int J Oral Sci, 2011, 3(3): 107-116.

[33] King R S, Newmark P A. The cell biology of regeneration. J Cell Biol, 2012,196(5): 553-562.

[34] Martinod E, Seguin A, Radu A M, et al. Airway transplantation: a challenge for regenerative medicine. Eur J Med Res, 2013,18(1): 25.

[35] Urciuolo F, Imparato G, Totaro A, et al. Building a tissue in vitro from the bottom up: implications in regenerative medicine. Methodist Debakey Cardiovasc J, 2013, 9(4): 213-217.

[36] Khademhosseini A. Experimental approaches to tissue engineering. J Vis Exp,2007, (7): 272.

[37] Liu X Y, Chen J, Zhou Q, et al. In vitro tissue engineering of lamellar cornea using human amniotic epithelial cells and rabbit cornea stroma. Int J Ophthalmol, 2013, 6(4): 425-429.

[38] Vunjak-Novakovic G. Tissue engineering strategies for skeletal repair. HSS J, 2012, 8(1): 57-58.

[39] Khademhosseini A. Experimental approaches to tissue engineering. J Vis Exp, 2007, (7): 272.

[40] Mangera A, Chapple C R. Tissue engineering in urethral reconstruction—an update. Asian J Androl, 2013,15(1): 89-92.

[41] Tucker B, Khan W, Al-Rashid M, et al. Tissue engineering for the meniscus: a review of the literature. Open Orthop J, 2012, 6: 348-351.

[42] Orlando G, Wood K J, Coppi P D, et al. Regenerative medicine as applied to general surgery. Ann Surg, 2012, 255(5): 867-880.

[43] Carbone M, Lerut J, Neuberger J. How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology? World J Gastroenterol, 2012,18(47): 6908-6917.

[44] Badylak S F, Nerem R M. Progress in tissue engineering and regenerative medicine. Proc Natl Acad Sci USA, 2010,107(8): 3285-3286.

[45] Nerem R M. Regenerative medicine: the emergence of an industry. J R Soc Interface, 2010, 7(Suppl 6): S771-S775.

[46] Ambrosio F, Wolf S L, Delitto A, et al. The emerging relationship between regenerative medicine and physical therapeutics. Phys Ther, 2010, 90(12): 1807-1814.

[47] Polak D J. Regenerative medicine. Opportunities and challenges: a brief overview. J R Soc Interface, 2010, 7(Suppl 6): S777-S781.

[48] Longaker M T. Jay & Margie grosfeld lecture: “regenerative medicine: a surgeon's perspective”. J Pediatr Surg, 2010, 45(1): 11-18.

[49] Astori G, Soncin S, Cicero V L, et al. Bone marrow derived stem cells in regenerative medicine as Advanced Therapy Medicinal Products. Am J Transl Res, 2010, 2(3): 285-295.

[50] Orlando G, Baptista P, Birchall M, et al. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int, 2011, 24(3): 10.

[51] Song F, Li B, Stocum D L. Amphibians as research models for regenerative medicine. Organogenesis, 2010, 6(3): 141-150.

[52] Nelson T J, Behfar A, Terzic A. Strategies for therapeutic repair: the “R3” regenerative medicine paradigm. Clin Transl Sci, 2008, 1(2): 168-171.

[53] Petersen T, Niklason L. Cellular lifespan and regenerative medicine. Biomaterials, 2007,28(26): 3751-3756.

[54] Yokoo T, Fukui A, Kobayashi E. Application of regenerative medicine for kidney diseases. Organogenesis, 2007, 3(1): 34-43.

[55] 王正国. 再生医学——机遇与挑战.中华创伤杂志, 2006, 22 (1): 1-4.

[56] Raggi C, Berardi A C. Mesenchymal stem cells, aging and regenerative medicine. Muscles Ligaments Tendons J, 2012, 2(3): 239-242.

[57] Lau A N, Goodwin M, Kim C F, et al. Stem cells and regenerative medicine in lung biology and diseases. Mol Ther, 2012, 20(6): 1116-1130.

[58] Liu Z C, Chang T M S. Artificial cell Microencapsulated stem cells in regenerative medicine, tissue engineering and cell therapy. Adv Exp Med Biol, 2010, 670: 68-79.

[59] Liu Y H, Karra R, Wu S M.Cardiovascular stem cells in regenerative medicine: ready for prime time? Drug Discov Today Ther Strateg, 2008, 5(4): 201-207.

[60] McMahon D S, Thorsteinsdóttir H, Singer P A, et al. Cultivating regenerative medicine innovation in China. Regen. Med, 2010, 5(1):35-44.

[61] 付蒙,张艳梅,王佃亮,孙晋伟.人羊膜间充质干细胞的生物学特性及临床前研究.中国生物工程杂志,2011,31(12):115-119. Fu M ,Zhang Y M ,Wang D L,et al.Biological properties and preclinical studies of humanamniotic mesenchymal stem cells.China Biotechnology,2011,31(12):115-119.

[62] 张艳梅,王佃亮.再生胰腺提取物诱导人羊膜间充质干细胞定向分化为胰岛素分泌细胞.生物工程学报, 2012,28(3):214-221. Zhang Y M, Wang D L, Zeng H Y, et al. Differentiation of human amniotic mesenchymal stem cells into insulin-secreting cellsinduced by regenerating pancreatic extract. Chin J Biotech, 2012, 28(2): 214-221.

[63] 张珍,王佃亮.干细胞库研究应用进展.中国医药生物技术,2012,7(2):136-139.

[64] Logue M, Savani B N. Understanding basic steps to hematopoietic stem cell transplantation evaluation. Am J Blood Res, 2013, 3(2): 102-106.

[65] Mittal S. Stem cell research: The India perspective. Perspect Clin Res, 2013, 4(1): 105-107.

[1] ZHU Shuai,JIN Ming-jie,YANG Shu-lin. A Review on Applications of 3D Bioprinting in Cartilage Tissue Regeneration Engineering[J]. China Biotechnology, 2021, 41(5): 65-71.
[2] YU Xing-ge,LIN Kai-li. The Application of Biomaterials Based on Natural Hydrogels in Bone Tissue Engineering[J]. China Biotechnology, 2020, 40(5): 69-77.
[3] WANG Yuan-dou,SU Feng,LI Su-ming. Research Progress of Photocrosslinked Hydrogel in Tissue Engineering[J]. China Biotechnology, 2020, 40(4): 91-96.
[4] YUAN Ya-kun,LIU Guang-yang,LIU Yong-jun,XIE Ya-fang,WU Hao. Comparison of Research and Clinical Transformation on Mesenchymal Stem Cells between China and the US[J]. China Biotechnology, 2020, 40(4): 97-107.
[5] LI Yu,ZHANG Xiao. The Experience and Enlightenment of Cell Therapy Regulation Dual-track System in Japan[J]. China Biotechnology, 2020, 40(1-2): 174-179.
[6] YAN Ge,QIAO Wei-hua,CAO Hong,SHI Jia-wei,DONG Nian-guo. Application of Surface Modification of Polydopamine in Tissue Engineering[J]. China Biotechnology, 2020, 40(12): 75-81.
[7] Hui-rong WU,Zhao-hui WEN. Application of Chitosan in Nerve Tissue Engineering[J]. China Biotechnology, 2019, 39(6): 73-77.
[8] Xi KANG,Ai-peng DENG,Shu-lin YANG. Research Progress of Chitosan Based Thermosensitive Hydrogels[J]. China Biotechnology, 2018, 38(5): 79-84.
[9] XI Lai-shun,YUN Peng,WANG Yuan-dou,ZHANG Guan-hong,XING Quan-sheng,CHEN Yang-sheng,SU Feng. Application of Shape Memory Polymer in Tissue Engineering[J]. China Biotechnology, 2018, 38(12): 76-81.
[10] SUN Huai-yuan,SONG Xiao-kang,LIAO Yue-hua,LI Xiao-ou. The Application of Piezoelectric Micro-jetting Technology in the Field of Cell Bioprinting[J]. China Biotechnology, 2018, 38(12): 82-90.
[11] LI Da-wei, HE Jin, HE Feng-li, LIU Ya-li, DENG Xu-dong, YE Ya-jing, YIN Da-chuan. Advances in Application of Silk Fibroin/Chitosan Composite in Tissue Engineering[J]. China Biotechnology, 2017, 37(10): 111-117.
[12] LUO Si-shi, TANG Shun-qing. Research Progress of Agarose in Tissue Engineering[J]. China Biotechnology, 2015, 35(6): 68-74.
[13] WANG Dian-liang. Three-dimensional Construction of Tissue Organ and Concept of in situ Tissue Engineering[J]. China Biotechnology, 2014, 34(8): 112-116.
[14] WANG Dian-liang. Seed Cells[J]. China Biotechnology, 2014, 34(7): 108-113.
[15] ZHANG Zhi-qiang, HUANG Xiang-hua, ZHAO Lin-yuan. The Effects of Microenvironment on Cells and The Application of Bionics in Tissue Engineering Scaffolds[J]. China Biotechnology, 2014, 34(4): 101-109.